The occurrence of different fusions involving the ABCB1 gene, which encodes multidrug resistance protein 1 (MDR1), was observed in post-treatment high-grade serous ovarian cancer (HGSC) and end-stage breast cancer samples [80]. The gene discussed is ABCB1; the disease is ovarian serous adenocarcinoma.